الاستثمار في القطاعات التحويلية في الأسواق الناشئة، وريادة الأصول الرقمية، والتوسع العالمي لمنظومة K11by AC الثقافية هونغ كونغ، 21 أيلول/سبتمبر 2025 – أعلنت مجموعة ألماد
Propelling transformative industries in emerging markets, driving digital assets and globalizing K11 by AC ecosystem HONG KONG SAR – Media OutReach Newswire – 22 September 2025 –
Angelini Pharma secures exclusive option to license global development and commercialization rights for SVG1051, a pre-clinical investigational novel compound with broad potential to treat brain
Angelini Pharma secures exclusive option to license global development and commercialization rights for SVG1051, a pre-clinical investigational novel compound with broad potential to treat brain
Angelini Pharma secures exclusive option to license global development and commercialization rights for SVG1051, a pre-clinical investigational novel compound with broad potential to treat brain
Angelini Pharma secures exclusive option to license global development and commercialization rights for SVG1051, a pre-clinical investigational novel compound with broad potential to treat brain